<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Grishkovskaya I</submitter><funding>BLRD VA</funding><funding>Austrian Science Fund FWF</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><pagination>8244-8261</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5437232</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>292(20)</volume><pubmed_abstract>Myeloperoxidase (MPO) is synthesized by neutrophil and monocyte precursor cells and contributes to host defense by mediating microbial killing. Although several steps in MPO biosynthesis and processing have been elucidated, many questions remained, such as the structure-function relationship of monomeric unprocessed proMPO &lt;i>versus&lt;/i> the mature dimeric MPO and the functional role of the propeptide. Here we have presented the first and high resolution (at 1.25 Å) crystal structure of proMPO and its solution structure obtained by small-angle X-ray scattering. Promyeloperoxidase hosts five occupied glycosylation sites and six intrachain cystine bridges with Cys-158 of the very flexible N-terminal propeptide being covalently linked to Cys-319 and thereby hindering homodimerization. Furtherm</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation.</pubmed_title><pmcid>PMC5437232</pmcid><funding_grant_id>W 1224</funding_grant_id><funding_grant_id>AI116546</funding_grant_id><funding_grant_id>R01 AI116546</funding_grant_id><funding_grant_id>I01 BX000513</funding_grant_id><funding_grant_id>P01 AI044642</funding_grant_id><funding_grant_id>AI044642</funding_grant_id><pubmed_authors>Obinger C</pubmed_authors><pubmed_authors>Hofbauer S</pubmed_authors><pubmed_authors>Paumann-Page M</pubmed_authors><pubmed_authors>Soudi M</pubmed_authors><pubmed_authors>Grishkovskaya I</pubmed_authors><pubmed_authors>Djinovic-Carugo K</pubmed_authors><pubmed_authors>Tscheliessnig R</pubmed_authors><pubmed_authors>Stampler J</pubmed_authors><pubmed_authors>Nauseef WM</pubmed_authors><pubmed_authors>Furtmuller PG</pubmed_authors><pubmed_authors>Sevcnikar B</pubmed_authors><pubmed_authors>Oostenbrink C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation.</name><description>Myeloperoxidase (MPO) is synthesized by neutrophil and monocyte precursor cells and contributes to host defense by mediating microbial killing. Although several steps in MPO biosynthesis and processing have been elucidated, many questions remained, such as the structure-function relationship of monomeric unprocessed proMPO &lt;i>versus&lt;/i> the mature dimeric MPO and the functional role of the propeptide. Here we have presented the first and high resolution (at 1.25 Å) crystal structure of proMPO and its solution structure obtained by small-angle X-ray scattering. Promyeloperoxidase hosts five occupied glycosylation sites and six intrachain cystine bridges with Cys-158 of the very flexible N-terminal propeptide being covalently linked to Cys-319 and thereby hindering homodimerization. Furtherm</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2025-04-26T06:03:49.854Z</modification><creation>2019-03-27T02:45:23Z</creation></dates><accession>S-EPMC5437232</accession><cross_references><pubmed>28348079</pubmed><doi>10.1074/jbc.M117.775031</doi></cross_references></HashMap>